
SIGA Technologies Inc is a commercial-stage pharmaceutical company focused on the health security market. The company's lead product is TPOXX, an orally administered antiviral drug for the treatment of human smallpox disease caused by the variola virus. Its products target orthopoxvirus infections i... SIGA Technologies Inc is a commercial-stage pharmaceutical company focused on the health security market. The company's lead product is TPOXX, an orally administered antiviral drug for the treatment of human smallpox disease caused by the variola virus. Its products target orthopoxvirus infections including smallpox. Show more
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.23 | 4.18181818182 | 5.5 | 5.83 | 5.16 | 456600 | 5.53728669 | CS |
4 | -0.15 | -2.55102040816 | 5.88 | 6.25 | 5.16 | 519767 | 5.77324551 | CS |
12 | -0.41 | -6.67752442997 | 6.14 | 6.61 | 5.16 | 425197 | 5.96705361 | CS |
26 | -2.165 | -27.4224192527 | 7.895 | 8.75 | 5.16 | 490146 | 6.65345894 | CS |
52 | 0.85 | 17.4180327869 | 4.88 | 12.83 | 4.75 | 862029 | 8.33483697 | CS |
156 | -1.1 | -16.1054172767 | 6.83 | 26.99 | 4.215 | 2237546 | 12.67152369 | CS |
260 | 0.59 | 11.4785992218 | 5.14 | 26.99 | 3.96 | 1439737 | 12.21323404 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales